Study of NS-9 in Patients With Liver Metastases
NCT00094003
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Liver Neoplasms
Neoplasm Metastasis
Local Neoplasm Recurrences
Interventions
DRUG:
NS-9 [Poly I: Poly C]
Sponsor
NS Pharma, Inc.